NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases
1. CMS maintains the current MS-DRG assignment for RNS System procedures. 2. This decision supports hospitals treating Medicare patients with epilepsy. 3. NeuroPace is committed to enhancing reimbursement policies with CMS. 4. RNS System offers personalized treatment for drug-resistant epilepsy. 5. The company faces risks regarding pricing and reimbursement availability.